Efalizumab-induced hypertrichosis.
Rallis
E
E
Tapinis
P
P
Verros
C D
CD
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*; D007155:Immunologic Factors / Q000009:adverse effects*; D011565:Psoriasis / Q000188:drug therapy; D013739:Testosterone / Q000097:blood; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D013739:Testosterone; C472181:efalizumab